Cassaday & Co Wealth Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,499
| Closed | -$228K | – | 319 |
|
|
2024
Q4 | $228K | Hold |
4,499
| – | – | 0.01% | 294 |
|
|
2024
Q3 | $287K | Hold |
4,499
| – | – | 0.01% | 249 |
|
|
2024
Q2 | $267K | Hold |
4,499
| – | – | 0.01% | 241 |
|
|
2024
Q1 | $259K | Hold |
4,499
| – | – | 0.01% | 249 |
|
|
2023
Q4 | $257K | Sell |
4,499
-29,415
| -87% | -$1.68M | 0.01% | 234 |
|
|
2023
Q3 | $1.63M | Hold |
33,914
| – | – | 0.07% | 60 |
|
|
2023
Q2 | $1.76M | Buy |
33,914
+80
| +0.2% | +$4.16K | 0.07% | 60 |
|
|
2023
Q1 | $1.83M | Buy |
33,834
+521
| +2% | +$28.2K | 0.08% | 55 |
|
|
2022
Q4 | $1.92M | Buy |
+33,313
| New | +$1.92M | 0.09% | 53 |
|